Abstract
From September 2014 to April 2015, 6 persons who had occupational exposures to Zaire ebolavirus in West Africa received investigational agent rVSV-ZEBOV or TKM-100802 for postexposure prophylaxis and were monitored in the United States. All patients experienced self-limited symptoms after postexposure prophylaxis; none developed Ebola virus disease.
Original language | English (US) |
---|---|
Pages (from-to) | 376-379 |
Number of pages | 4 |
Journal | Clinical Infectious Diseases |
Volume | 63 |
Issue number | 3 |
DOIs | |
State | Published - Aug 1 2016 |
Keywords
- Ebola virus
- TKM-Ebola
- postexposure prophylaxis
- vesicular stomatitis virus
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases